Nino Niederreiter has been bold enough with his hobbies to ride on the outside of an airplane .
NYS Entity Status
NYS Filing Date
JULY 29, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - GSS SPORT INC.
Around the Web
- Signed for 5 years with Wild, now Niederreiter can relax
Tuesday Aug 8, 2017
- Ryder Trucks Launches Campaign With 'Inc.'
Tuesday Sep 19, 2017
"The campaign underscores how truck owners are essentially dumping cash all over America's highways from all the hidden costs required in maintaining a private fleet," Ryder's Karen Jones tells"Marketing Daily."
- NY's Hometown Paper Once Again Owned By Chicago Publisher
Tuesday Sep 5, 2017
New York's hometown paper is once again owned by a Chicago-based newspaper holding company, following the 'New York Daily News' sale on Monday to Tronc Inc. In a way, it's like deja vu. Tronc wasformerly Tribune Publishing, the publisher of the 'Chicago Tribune,' which originally created the 'New York Daily News' nearly a century ago.
- Ex-Stars coach Lindy Ruff hired as NY Rangers assistant
Monday Jul 10, 2017
New York Rangers have hired longtime NHL head coach Lindy Ruff
- CRISPR Pioneer Jennifer Doudna On Gene Editing’s Potential For Good And Evil
By Noah Robischon - Tuesday Jun 20, 2017
CRISPR coinventor Jennifer Doudna talks about developing the gene-editing tool that’s poised to change the world.
Scientists now have a relatively easy and inexpensive way to read, write, and edit the building blocks of life—the genome-editing technique known as CRISPR-Cas9. And while the technology was developed only five years ago, CRISPR’s ability to target—and modify—specific sections of DNA is already supercharging the pace of scientific breakthroughs in medicine and agriculture. It’s even being used to try to bring the woolly mammoth back to life. Investors (including Bill Gates and Sean Parker) and pharmaceutical companies have plowed millions of dollars into CRISPR-driven research; philanthropies have granted millions more to support scientists working on cures for genetic diseases; and in China, at least seven human clinical trials are moving forward. But it all started when a small group of scientists, working in collaboration, stumbled on an organic biological process that had existed for millennia. Among the leaders was molecular biologist Jennifer Doudna, who heads the Doudna Lab at the University of California, Berkeley. She’s the coauthor of a new book tracing CRISPR’s evolution, A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution. “[CRISPR] is a great illustration of how technologies are born,” says Doudna. “They often come about in unexpected ways.” And the outcomes can be just as unpredictable, and dangerous—a fact that has prompted her to become a global advocate for the responsible use of CRISPR. In this excerpt, Doudna talks about its transformative power. —Noah Robischon
- Lincoln-Sudbury Claims State Title to Round Out Final Nike/USL HSB Top 25
By mschneider - Tuesday Jun 20, 2017